Tanfac Inds.Q1 FY27
Tanfac Inds. Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹3,061P/E: 104.0Market Cap: ₹7.0K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 2
Margin
Category 1
Fundraise
Yes
Order
Yes
Capex
Yes
4 of 5 growth signals are positive — a strong management growth story.
Full analysisRevenue guidance
Category 2- →FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6).
- →FY28 revenue expected to grow over 60% due to ramp-up of new projects and inorganic fluoride products (Page 6).
- →R-32 volume guidance for FY28 is conservatively at 80%-85% utilization (Page 9).
- →Solar grade DHF capacity planned to expand alongside solar wafer capacity growth from 35 GW to 210 GW by FY29 (Page 20).
- →AHF capacity expansion of 20,000 to 30,000 tons planned with commissioning expected by FY28 (Page 15).
- →Post R-32 project commissioning, revenue from R-32 alone expected to be INR 900-1,000 crores, with exports increasing to 50% of revenue (Page 9).
- →Specialty fluorides and electronic grade fluorochemicals are also key growth areas being evaluated for future expansion (Pages 7, 15).
Margin guidance
Category 1- →TANFAC targets 30% revenue growth in FY27 driven by new project launch (HFC-32) and ramp-up of existing capacities.
- →FY28 revenue is expected to grow over 60% due to further ramp-up of the new project and expansion into inorganic fluorides and value-added products.
- →EBITDA margins anticipated to improve to 16-19% from Q2 FY27 onward, with further expansion to around 25% once the HFC-32 project is operational.
- →Post commissioning of R-32 capacity, stable and higher margin profile expected, reducing volatility currently seen due to raw material price fluctuations.
- →Projected cash flows expected to surpass INR 300 crores from the coming year, significantly up from current PAT levels (~INR 100 crores).
- →Long-term contracts with pass-through pricing mechanisms ensure predictability in margins and earnings.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →The transcript does not mention any current or upcoming fundraising through debt or equity.
- →It highlights a recent successful completion of a INR 250 crores Qualified Institutional Placement (equity fundraising), which has strengthened the company's capital structure.
- →TANFAC is now net debt-free and has sufficient financial flexibility to fund ongoing expansion projects without taking on undue leverage.
- →Future expansions and capex will be funded internally rather than through fresh debt or equity as per current disclosures.
Order book
Yes- →TANFAC Industries Limited has two firm contracts for R-32 and one Memorandum of Understanding (MoU) which is expected to convert into a contract soon.
- →The MoU offtake is for 5,000 tons.
- →Around 80% to 85% of the solar grade DHF plant capacity is contracted.
- →Approximately 65% to 70% of the R-32 capacity is already booked under long-term contracts spanning 5 to 8 years.
- →Long-term contracts include take-or-pay terms with pass-through pricing mechanisms.
- →The company has placed about 65% of R-32 volume at a fixed EBITDA margin with remaining 30% sold on the spot market.
- →Solar grade DHF capacity is currently fully sold out.
- →TANFAC is evaluating technology tie-ups for electronic grade products and considering expansion capex accordingly.
Capex plans
Yes- →Current ongoing capex: HFC-32 project with a total committed liability of INR 315 crores out of INR 395 crores; about INR 100 crores spent so far; commissioning expected by November-end 2026.
- →Future capex plans (~INR 1,500 - 1,700 crores over next 4 years) include:
- → - Expansion of Solar Grade DHF capacity (INR 30-40 crores), starting 6 months post HFC-32 commissioning.
- → - Expansion of AHF (Anhydrous Hydrogen Fluoride) capacity (INR 120 crores), expected 12-15 months timeline.
- → - Investment in value-added fluorochemicals and electronic-grade products, including inorganic fluorides and fluoropolymers (INR 150 crores).
- → - Strategic focus on electronic grade HF for semiconductor applications, evaluating technology tie-ups to accelerate go-to-market.
- →Planned phased investments until 2030-31 focusing on solar grade DHF, AHF, electronic grade, HFOs, and high-performing fluoropolymers.
How does Tanfac Inds. rank vs peers in Chemicals & Petrochemicals?
Pro feature1Tanfac Inds.
Rev 2Mar 1
See full Chemicals & Petrochemicals sector rankings
How does Tanfac Inds. rank in Chemicals & Petrochemicals?
Compare Tanfac Inds. against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.